Low dose of oral alendronate decreases bone turnover in Japanese patients with Paget's disease of bone.
Takada
Junichi
J
Department of Orthopaedic Surgery, Sapporo Medical University, South-1, West-16, Chuo-ku, Sapporo 060-8543, Japan. jtakada@sapmed.ac.jp
Iba
Kousuke
K
Yamashita
Toshihiko
T
D000284:Administration, Oral; D000368:Aged; D019386:Alendronate / Q000008:administration & dosage*; D000469:Alkaline Phosphatase / Q000097:blood; D000596:Amino Acids / Q000652:urine; D015415:Biomarkers / Q000378:metabolism; D016723:Bone Remodeling / Q000187:drug effects*; D001862:Bone Resorption / Q000188:drug therapy / Q000503:physiopathology; D003094:Collagen / Q000652:urine; D024042:Collagen Type I; D005260:Female; D006801:Humans; D007564:Japan; D008297:Male; D010001:Osteitis Deformans / Q000188:drug therapy* / Q000503:physiopathology; D010012:Osteogenesis / Q000187:drug effects; D010455:Peptides / Q000652:urine
D000596:Amino Acids; D015415:Biomarkers; D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; C036020:deoxypyridinoline; D003094:Collagen; D000469:Alkaline Phosphatase; D019386:Alendronate